# Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in ST-Elevation Myocardial Infarction (STEMI)

Study · id `cardio:ct-nct01324453` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01324453](<https://clinicaltrials.gov/study/NCT01324453>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01324453

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease; Acute care and long-term living  

## In plain language

A phase 1/2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.

## Technical summary

Registry record NCT01324453. Randomized; no masking; primary purpose treatment. Start 2011-03 (registry gives no type); primary completion 2016-11 (actual). Results posted on 2018-04-17.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 1/2
- Enrolled: 103 participants (enrolled count; ClinicalTrials.gov record NCT01324453, source copy `cardio:ctgov-nct01324453-2019-06-05`, retrieved 2026-10-26)
- Start date: 2011-03 (registry gives no type) (ClinicalTrials.gov record NCT01324453, source copy `cardio:ctgov-nct01324453-2019-06-05`, retrieved 2026-10-26)
- Primary completion: 2016-11 (actual) (ClinicalTrials.gov record NCT01324453, source copy `cardio:ctgov-nct01324453-2019-06-05`, retrieved 2026-10-26)
- Completion: 2017-03 (actual) (ClinicalTrials.gov record NCT01324453, source copy `cardio:ctgov-nct01324453-2019-06-05`, retrieved 2026-10-26)
- Results first posted: 2018-04-17 (ClinicalTrials.gov record NCT01324453, source copy `cardio:ctgov-nct01324453-2019-06-05`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT01324453, source copy `cardio:ctgov-nct01324453-2019-06-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01324453-2019-06-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Phase II Clinical Trial to Evaluate the Benefits of Postconditioning in ST-Elevation Myocardial Infarction (STEMI)
- Condition: Acute Myocardial Infarction
- Intervention (Procedure): Post Conditioning + Primary PCI
- Intervention (Procedure): Standard Primary PCI
- Lead sponsor: Minneapolis Heart Institute Foundation
- Lead sponsor class: OTHER
- Collaborator: National Heart, Lung, and Blood Institute (NHLBI)
- Collaborator class: NIH

## Connected pages

- Registry condition terms include this condition: Heart attack (myocardial infarction) (`cardio:myocardial-infarction`)
- Registry condition terms include this condition: ST-elevation heart attack (STEMI) (`cardio:stemi`)
- Registry lists this organization as the lead sponsor: Minneapolis Heart Institute Foundation (`cardio:org-minneapolis-heart-institute-foundation`)
- Registry lists this organization as a collaborator: National Heart, Lung, and Blood Institute (`cardio:nhlbi`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: NHLBI-Sponsored Randomized Trial of Postconditioning During Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (`cardio:pubmed-30602360`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 181209d853c34d913424928b68b0ea45648024fc2c5a15952bf18881714b5b8a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
